Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimbite-MV1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Pure and Cure Healthcare Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimbite-MV1 Tablet SR

Diabelite-XR, a dual-action antidiabetic medication, is prescribed for adult patients with type 2 diabetes. This formulation manages blood glucose levels. Diabelite-XR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Diabelite-XR is one element of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Awareness of these symptoms and preparedness with a fast-acting glucose source (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Diabelite-XR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) may be recommended by your doctor.

Primary Ingredients of Glimbite-MV1 Tablet SR

There is no text provided to rephrase.

Uses of Glimbite-MV1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimbite-MV1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Glimbite-MV1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

Common Side effects of Glimbite-MV1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimbite-MV1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Glimbite-MV1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Glimbite-MV1 Tablet SR works:

Extended-release Glimbite-MV1 tablets contain a triple-action formulation of antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimbite-MV1 Tablet SR and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimbite-MV1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimbite-MV1 tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimbite-MV1 Tablet SR is contraindicated in patients with kidney impairment and should be omitted. A physician's consultation is advised. Patients with severe renal dysfunction should not take Glimbite-MV1 Tablet SR.

LiverLiverCAUTION

Exercise caution when prescribing Glimbite-MV1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Glimbite-MV1 Tablet SR therapy with a reduced initial dose; avoid use in those with severe liver disease.

What if you forget to take Glimbite-MV1 Tablet SR :

Should you forget a Glimbite-MV1 Tablet SR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbite-MV1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimbite-MV1 Tablet SR

Glimbite-MV1 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Glimbite-MV1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infection.
Glimbite-MV1 Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glimbite-MV1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimbite-MV1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimbite-MV1 Tablet SR
125
MRP 152
17% off